From DCAT Value Chain Insights (VCI)
UK-based sterile-filling specialist Symbiosis Pharmaceutical Services has appointed a US-based business development manager, Derek Richards, to oversee its business development activities across the East Coast. The company also has plans to appoint a senior executive to look after commercial interests on the West Coast.
Mr. Richards will work closely with Symbiosis’ existing commercial team in Europe to help build the company’s profile in the US. Symbiosis’ specializes in sterile injectables and the aseptic manufacturing of drug products, which are either liquid or lyophilized formulations filled into vials. Its core manufacturing capability is undertaken within a purpose-built facility in Stirling, Scotland, designed for the manufacture of sterile drug products at clinical and niche market scale. He has more than 20 years of experience working in the pharmaceutical industry.
Source: Symbiosis Pharmaceutical Services
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription